Bloom Energy just posted a blowout Q1, with revenue surging 130% year-over-year. But as the company raises its 2026 guidance, some analysts question whether the stock can sustain its momentum — or if it’s already priced for perfection.
Bloom Energy (BE) shares have skyrocketed after a blockbuster Q1 2026 earnings beat, a raised full-year guidance to $3.4B–$3.8B, and an expanded Oracle partnership for AI data center power. With the stock up over 117% in the past month and trading well above analyst price targets, investors are split on whether this is a stretched AI play or a growth story still in its early innings.
Bloom Energy (BE) is drawing serious attention from top investors like Stanley Druckenmiller and Jim Cramer, as JPMorgan and Clear Street raise price targets following a strong Q1 2026 performance. With solid oxide fuel cells powering data centers and industrial sites, the company is positioned for growth—but not everyone is convinced.
Bloom Energy is experiencing unprecedented demand for its solid-oxide fuel cells as hyperscalers seek to secure power for their data centers. With earnings due April 28, the stock's valuation raises questions.
The fuel cell stock is charging ahead this week, lifted by a wave of analyst upgrades and lingering excitement over its Oracle AI infrastructure deal.
Following strong fourth-quarter results, multiple analysts have raised price targets for Bloom Energy (BE), citing broad-based demand for its fuel cell power solutions, particularly from the data center and industrial sectors.
Mizuho, UBS, and Bank of America have all raised their price targets for Bloom Energy (NYSE: BE) following its robust Q4 2025 results, citing improved margins, better capacity use, and strong forward visibility.
With Apple expected to enter the foldable phone market as early as September, Barclays sees a buying opportunity in two overlooked chipmakers: Skyworks Solutions and Qorvo.
When the Google parent reports earnings on Wednesday, these will be the two most important metrics to watch.
The pharma giant’s yield has climbed as its stock stumbled. Here’s what investors need to weigh.
RS Technologies (TSE:3445) has surged 68% in the past month, drawing fresh attention after an April 24 board meeting to consider restricted stock compensation. With earnings due May 14 and a P/E of 17.4x — below both its peers and the broader Japanese semiconductor sector — the stock looks undervalued on one metric, but a DCF model suggests it may be overpriced. We break down the mixed signals, the wafer reclamation tailwind, and what investors should watch next.
Cognex shares have more than doubled over the past year, but a closer look at valuation metrics suggests the stock may be running ahead of fundamentals. With a DCF-based fair value estimate of just $38.37 per share, some analysts and investors are questioning whether the current price of $62.26 leaves room for further gains — or sets the stage for a correction.
Rep. Daniel Meuser has consistently sold shares of the AI chipmaker Nvidia since 2022, a strategy that has cost him potential profits exceeding 630% as the stock soared. The trades, some executed by his spouse, renew scrutiny over congressional stock activity and timing.
The CFO of this power semiconductor firm unloaded over 8,000 shares amid a massive rally. But the sale was pre-planned, and insiders still hold big positions.
John Ternus will take over as Apple's new CEO on September 1, raising questions about the company's future direction and stock performance.
The semiconductor testing equipment maker posted a beat on Q1 earnings and issued upbeat guidance, but investors cashed out on valuation concerns, sending shares down more than 11% for the week.
Shares of Pfizer have fallen more than 50% since their 2021 high, but with a dividend yield of 6.4%, some investors are asking whether the pharma giant is a value trap or a long-term opportunity.
Plug Power shares have surged over the past year, but the stock remains below $3. A closer look at its history of dilution and profitability challenges suggests the road to $30 is anything but certain.
A good business doesn't always make a good stock. Palantir’s latest numbers were impressive, but its valuation remains a towering concern.
For the first time in nearly two years, Berkshire Hathaway repurchased $234 million of its own shares. It’s a small buyback, but the signal behind it could be huge for investors watching the conglomerate’s next move.
